Archives for October 16, 2003

← 2003

Sartorius/KMI go global

Sartorius North America and KMI/Parexel International have formed an alliance that will improve the geographic reach of their biopharmaceutical production and consultancy services.

Medarex works on its Abs

Medarex of the USA, a specialist in producing fully-human antibodies, has entered into two new agreements aimed at improving the properties of its drug candidates.

Small molecules for psoriasis

An alliance between two German companies - 4SC and SWITCH Biotech - has been set up to focus on the discovery of small-molecule compounds for the treatment of psoriasis.

Researchers find cause of gene therapy cancer

Researchers have established the cause of the leukaemia which developed in two young patients taking part in a pioneering gene therapy trial to treat the fatal 'baby-in-a-bubble' syndrome.

Akzo profits down, as expected

Dutch pharmaceuticals, chemicals and coatings group Akzo Nobel has reported a 23 per cent decline in third-quarter earnings, roughly in line with expectations, on the back of continued pressure on its pharmaceuticals division.

Measuring small RNA sequences

Ambion has developed technique that allows easier monitoring of short RNA sequences in a variety of sample types and is 100-500 more sensitive than Northern blot analysis.